Pneumonia in the very old

Lancet Infectious Diseases

Volumn 4, Issue 2, 2004, Pages 112-124

  Janssens, Jean Paul ^a   Krause, Karl Heinz ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; DOXYCYCLINE; INFLUENZA VACCINE; MACROLIDE; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; COXIELLA BURNETII; DISEASE SEVERITY; ESCHERICHIA COLI; GERIATRIC DISORDER; HAEMOPHILUS INFLUENZAE; HUMAN; INFLUENZA VIRUS A; KLEBSIELLA PNEUMONIAE; LEGIONELLA PNEUMOPHILA; MEDICAL ETHICS; MORAXELLA CATARRHALIS; MORTALITY; MYCOPLASMA PNEUMONIAE; NURSING HOME ACQUIRED PNEUMONIA; PARAINFLUENZA VIRUS; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0842305165     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(04)00931-4     Document Type: Review

References (160)

1. Fein A. Pneumonia in the elderly. Special diagnostic and therapeutic considerations. Med Clin N Amer. 78:1994;1015-1033.
2. El-Solh A.A., Sikka P., Ramadan F., Davies J. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med. 163:2001;645-651.
3. Kaplan V., Clermont G., Griffin M.F., et al. Pneumonia: still the old man's friend? Arch Intern Med. 163:2003;317-323.
4. Janssens J.P., Pache J.C., Nicod L.P. Physiological changes in respiratory function associated with ageing. Eur Respir J. 13:1999;197-205.
5. Tolep K., Kelsen S. Effect of aging on respiratory skeletal muscles. Clin Chest Med. 14:1993;363-378.
6. Enright P.L., Kronmal R.A., Manolio T.A., Schenker M.B., Hyatt R.E. Respiratory muscle strength in the elderly: correlates and reference values. Am J Respir Crit Care Med. 149:1994;430-438.
7. Evans S., Watson L., Hawkins M., Cowley A., Johnston I., Kinnear W. Respiratory muscle strength in chronic heart failure. Thorax. 50:1995;625-628.
8. Nishimura Y., Maeda H., Tanaka K., Nakamura H., Hashimoto Y., Yokoyama M. Respiratory muscle strength and hemodynamics in chronic heart failure. Chest. 105:1994;355-359.
9. Tzelepis G.E., McCool F.D., Friedman J.H., Hoppin FG Jr. Respiratory muscle dysfunction in Parkinson's disease. Am Rev Respir Dis. 138:1988;266-271.
10. Brown L.K. Respiratory dysfunction in Parkinson's disease. Clin Chest Med. 15:1994;715-727.
11. Meyer K., Ershler W., Rosenthal N., Xing-Gu L., Peterson K. Immune dysregulation in the aging human lung. Am J Respir Crit Care Med. 153:1996;1072-1079.
12. Ho J.C., Chan K.N., Hu W.H., et al. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med. 163:2001;983-988.
13. Fein A.M., Feinsilver S.H., Niederman M.S. Atypical manifestations of pneumonia in the elderly. Clin Chest Med. 12:1991;319-336.
14. Kronenberg R., Drage G. Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal man. J Clin Invest. 52:1973;1812-1819.
15. Huang Y.P., Gauthey L., Michel M., et al. The relationship between influenza vaccine-induced specific antibody responses and vaccine-induced nonspecific autoantibody responses in healthy older women. J Gerontol. 47:1992;50-55.
16. Miller C., Kelsoe G. Ig VH hypermutation is absent in the germinal centers of aged mice. J Immunol. 155:1995;3377-3384.
17. Nicoletti C., Yang X., Cerny J. Repertorial diversity of antibody response to bacterial antigens in aged mice. Phosphorylcholine antibody from young and aged mice differ in structure and protectice activity aagainst infection with Streptococcus pneumoniae. J Immunol. 150:1993;543-549.
18. Gyetko M.R., Toews G.B. Immunology of the aging lung. Clin Chest Med. 14:1993;379-391.
19. Marik P.E. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 344:2001;665-671.
20. Kikuchi R., Watabe N., Konno T., Mishina N., Sekizawa K., Sasaki H. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Care Med. 150:1994;251-253.
21. Horner J., Alberts M.J., Dawson D.V., Cook G.M. Swallowing in Alzheimer's disease. Alzheimer Dis Assoc Disord. 8:1994;177-189.
22. Horner J., Massey E.W., Riski J.E., Lathrop D.L., Chase K.N. Aspiration following stroke: clinical correlates and outcome. Neurology. 38:1988;1359-1362.
23. Strong R.M., Condon S.C., Solinger M.R., Namihas B.N., Ito-Wong L.A., Leuty J.E. Equal aspiration rates from postpylorus and intragastric-placed small-bore nasoenteric feeding tubes: a randomized, prospective study. J Parenter Enteral Nutr. 16:1992;59-63.
24. Croghan J.E., Burke E.M., Caplan S., Denman S. Pilot study of 12-month outcomes of nursing home patients with aspiration on videofluoroscopy. Dysphagia. 9:1994;141-146.
25. Tracy J.F., Logemann J.A., Kahrilas P.J., Jacob P., Kobara M., Krugler C. Preliminary observations on the effects of age on oropharyngeal deglutition. Dysphagia. 4:1989;90-94.
26. Valenti W.M., Trudell R.G., Bentley D.W. Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged. N Engl J Med. 298:1978;1108-1111.
27. Johanson W.G., Pierce A.K., Sanford J.P. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med. 281:1969;1137-1140.
28. Palmer L.B., Albulak K., Fields S., Filkin A.M., Simon S., Smaldone G.C. Oral clearance and pathogenic oropharyngeal colonization in the elderly. Am J Respir Crit Care Med. 164:2001;464-468.
29. Leibovitz A., Plotnikov G., Habot B., Rosenberg M., Segal R. Pathogenic colonization of oral flora in frail elderly patients fed by nasogastric tube or percutaneous enterogastric tube. J Gerontol A Biol Sci Med Sci. 58:2003;52-55.
30. Terpenning M.S., Taylor G.W., Lopatin D.E., Kerr C.K., Dominguez B.L., Loesche W.J. Aspiration pneumonia: dental and oral risk factors in an older veteran population. J Am Geriatr Soc. 49:2001;557-563.
31. Imsand M., Janssens J.P., Auckenthaler R., Mojon P., Budtz-Jorgenson E. Bronchopneumonia and oral health in hospitalized older patients. A pilot study. Gerodontology. 19:2003;66-72.
32. Medina-Walpole A.M., Katz P.R. Nursing home-acquired pneumonia. J Am Geriatr Soc. 47:1999;1005-1015.
33. Terpenning M., Shay K. Oral health is cost-effective to maintain but costly to ignore. J Am Geriatr Soc. 50:2002;584-585.
34. Yoneyama T., Yoshida M., Ohrui T., et al. Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc. 50:2002;430-433.
35. Kaplan V., Angus D.C., Griffin M.F., Clermont G., Scott Watson R., Linde-Zwirble W.T. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 165:2002;766-772.
36. Riquelme R., Torres A., El-Ebiary M., et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med. 154:1996;1450-1455.
37. Riquelme R., Torres A., El-Ebiary M., et al. Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am J Respir Crit Care Med. 156:1997;1908-1914.
38. Zalacain R., Torres A., Celis R., et al. Community-acquired pneumonia in the elderly: Spanish multicentre study. Eur Respir J. 21:2003;294-302.
39. Lim W.S., Macfarlane J.T. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J. 18:2001;362-368.
40. Lieberman D., Schlaeffer F., Porath A. Community-acquired pneumonia in old age: a prospective study of 91 patients admitted from home. Age Ageing. 26:1997;69-75.
41. Marrie T.J., Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc. 45:1997;50-55.
42. McFadden J.P., Price R.C., Eastwood H.D., Briggs R.S. Raised respiratory rate in elderly patients: a valuable physical sign. BMJ (Clin Res Ed). 284:1982;626-627.
43. Harper C., Newton P. Clinical aspects of pneumonia in the elderly veteran. J Am Geriatr Soc. 37:1989;867-872.
44. Johnson J.C., Jayadevappa R., Baccash P.D., Taylor L. Nonspecific presentation of pneumonia in hospitalized older people: age effect or dementia? J Am Geriatr Soc. 48:2000;1316-1320.
45. Venkatesan P., Gladman J., Macfarlane J.T., et al. A hospital study of community-acquired pneumonia in the elderly. Thorax. 45:1990;254-258.
46. Fedullo A.J., Swinburne A.J. Relationship of patient age to clinical features and outcome for in-hospital treatment of pneumonia. J Geront. 40:1985;29-33.
47. O'Keeffe S., Lavan J. The prognostic significance of delirium in older hospital patients. J Am Geriatr Soc. 45:1997;174-178.
48. Janssens J.P., Gauthey L., Herrmann F., Tkatch L., Michel J.P. Community-acquired pneumonia in older patients. J Am Geriatr Soc. 44:1996;539-544.
49. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 336:1997;243-250.
50. Ewig S., Kleinfeld T., Bauer T., Seifert K., Schafer H., Goke N. Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. Eur Respir J. 14:1999;370-375.
51. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med. 62:1987;195-220.
52. Seppa Y., Bloigu A., Honkanen P.O., Miettinen L., Syrjala H. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Arch Intern Med. 161:2001;2709-2713.
53. Loeb M., McGeer A., McArthur M., Walter S., Simor A. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med. 159:1999;2058-2064.
54. Lim W.S., Macfarlane J.T. Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged > or = 75 yrs. Eur Respir J. 17:2001;200-205.
55. Patel I., Seemungal T., Wilks M., Lloyd-Owen S., Donaldson G., Wedzicha J. Relationship between bacterial colonisation and frequency, character, and severity of COPD exacerbations. Thorax. 57:2002;759-764.
56. Ruiz M., Ewig S., Torres A., et al. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med. 160:1999;923-929.
57. Anon. Outbreak of pneumococcal pneumonia among unvaccinated residents of a nursing home - New Jersey, April. MMWR Morb Mortal Wkly Rep 2001. 50:2001;707-710.
58. Nuorti J.P., Butler J.C., Crutcher J.M., et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med. 338:1998;1861-1868.
59. Chan T., Ho S., Lai C., et al. Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong. Chemotherapy. 42:1996;150-156.
60. Muder R.R., Brennen C., Wagener M.M., et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med. 114:1991;107-112.
61. Von Eiff C., Becker K., Machka K., Stammer H., Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 344:2001;11-16.
62. Fein A.M., Niederman M.S. Severe pneumonia in the elderly. Med Clin N Amer. 10:1994;121-143.
63. Nicotra M.B., Rivera M., Dale A.M., Shepherd R., Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest. 108:1995;955-961.
64. Federal Agency for Public Health. La legionellose en Suisse de 1999 à 2001. Bulletin de l'OFSP 2003; 120: 116-120.
65. Stout J.E., Yu V.L. Legionellosis. N Engl J Med. 337:1997;682-687.
66. Helbig J.H., Uldum S.A., Luck P.C., Harrison T.G. Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA. J Med Microbiol. 50:2001;509-516.
67. Cunha B.A. Pneumonia in the elderly. Clin Microbiol Infect. 7:2001;581-588.
68. Bentley D.W. Bacterial pneumonia in the elderly: clinical features, diagnosis, etiology, and treatment. Gerontology. 30:1984;297-307.
69. Finegold S.M. Legionnaires' disease - still with us. N Engl J Med. 318:1988;571-573.
70. Storch G., Hayes P.S., Hill D.L., Baine W.B. Prevalence of antibody to Legionella pneumophila in middle-aged and elderly Americans. J Infect Dis. 140:1979;784-788.
71. Macfarlane J.T., Miller A.C., Roderick Smith W.H., Morris A.H., Rose D.H. Comparative radiographic features of community acquired Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and psittacosis. Thorax. 39:1984;28-33.
72. Stout J.E., Brennen C., Muder R.R. Legionnaires' disease in a newly constructed long-term care facility. J Am Geriatr Soc. 48:2000;1589-1592.
73. Stout J.E., Yu V.L., Muraca P., Joly J., Troup N., Tompkins L.S. Potable water as a cause of sporadic cases of community-acquired legionnaires' disease. N Engl J Med. 326:1992;151-155.
74. Troy C.J., Peeling R.W., Ellis A.G., et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA. 277:1997;1214-1218.
75. Falsey A.R., McCann R.M., Hall W.J., et al. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc. 43:1995;30-36.
76. Falsey A.R., Treanor J.J., Betts R.F., Walsh E.E. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc. 40:1992;115-119.
77. Falsey A.R., Cunningham C.K., Barker W.H., et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis. 172:1995;389-394.
78. Fernandez-Sabe N., Carratala J., Roson B., et al. Community-acquired pneumonia in very elderly patients. Causative organisms, clinical characteristics and outcomes. Medicine. 82:2003;159-169.
79. Saviteer S., Samsa G., Rutala W. Nosocomial infections in the elderly. Increased risk per hospital day. Am J Med. 84:1988;661-666.
80. Niederman M.S. Pneumonia in the elderly. Mahler D.A. Pulmonary disease in the elderly patient. New York: Marcel Dekker. 1993;279-315.
81. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement. Am J Respir Crit Care Med. 153:1996;1711-1725.
82. Villegas M.V., Labrada L.A., Saravia N.G. Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis. Chest. 118:2000;1355-1364.
83. Lombardi C., Spedini C., Lanzani G. Fiber bronchoscopy in old age. Its diagnostic importance, tolerability and safety. Recenti Prog Med. 86:1995;17-20.
84. Macfarlane J.T., Storr A., Wart M.J., Smith W.H. Safety, usefulness and acceptability of fibreoptic bronchoscopy in the elderly. Age Ageing. 10:1981;127-131.
85. Christe C., Janssens J.P., Armenian B., Herrmann F., Vogt N. Midazolam sedation for upper gastrointestinal endoscopy in older persons: a randomized, double-blind, placebo-controlled study. J Am Geriatr Soc. 48:2001;1398-1403.
86. Marrie T.J. Community-acquired pneumonia in the elderly. Clin Infect Dis. 31:2000;1066-1078.
87. Yoshikawa T.T., Norman D.C. Approach to fever and infection in the nursing home. J Am Geriatr Soc. 44:1996;74-82.
88. Federal Agency for Public Health. Panorama des maladies infectieuses déclarées en Suisse. Bulletin de l'Office Fédéral de la Santé Publique 1996; supplément 29.
89. Janssens J.P., Zellweger J.P. Epidémiologie, clinique, et traitement de la tuberculose chez les sujets âgés. Schweiz Med Wochenschr. 129:1999;80-89.
90. Chan C.H.S., Woo J., Or K.K.H., Chan R.C.Y., Cheung W. The effect of age on the presentation of patients with tuberculosis. Tubercle Lung Dis. 76:1995;290-294.
91. Korzeniewska-Kosela M., Krysl J., Müller N., Black W., Allen E., FitzGerald J.M. Tuberculosis in young adults and the elderly: a prospective comparison study. Chest. 106:1994;28-32.
92. Katz P., Reichman W., Dube D. Clinical features of tuberculosis in young and old veterans. J Am Geriatr Soc. 35:1987;512-515.
93. Mathur P., Sacks L., Auten G., Sall R., Levy C., Gordin F. Delayed diagnosis of pulmonary tuberculosis in city hospitals. Arch Intern Med. 154:1994;306-310.
94. Rieder H., Kelly G., Bloch A., Cauthen G., Snider D.J. Tuberculosis diagnosed at death in the United States. Chest. 100:1991;678-681.
95. Morris CDW. Pulmonary tuberculosis in the elderly: a different disease? Thorax. 45:1990;912-913.
96. Teale C., Goldman J.M., Pearson S.B. The association of age with the presentation and outcome of tuberculosis: a five-year survey. Age Ageing. 22:1993;289-293.
97. Schaberg T., Gialdroni-Grassi G., Huchon G., Leophonte P., Manresa F., Woodhead M. An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. Thorax. 51:1996;1017-1022.
98. Laszlo A., Gianelli S., Laurencet F., Krause K.H., Janssens J.P. Successful treatment of disseminated tuberculosis and acquired immunodeficiency syndrome in an 81-yr-old woman. Scand J Infect Dis. 35:2003;420-442.
99. Gordon S.M., Thompson S. The changing epidemiology of human immunodeficiency virus infection in older persons. J Am Geriatr Soc. 43:1995;7-9.
100. Thomas C., Jones T., Edson R. 74-year-old woman with dyspnea, fever and cough. Mayo Clin Proc. 70:1995;397-400.
101. Laszlo A., Lambert V., Michel J.P., Janssens J.P. Pneumopathie aiguë à Nocardia asteroides communautaire chez une patiente de 93 ans. Ann Med Interne. 152:2001;407-409.
102. De Fenoyl O., Alvarez M., Richet H., Febvre M., Rochemaure J. Nocardioses pulmonaires d'évolution aiguë. Deux observations diagnostiquées par fibroscopie bronchique. Guérison sous traitement. Ann Med Interne. 138:1987;382-384.
103. Allam M.F., Del Castillo A.S., Diaz-Molina C., Navajas R.F. Invasive pulmonary aspergillosis: identification of risk factors. Scand J Infect Dis. 34:2002;819-822.
104. Kennedy T.P., Weber D.J. Nontuberculous mycobacteria: an underappreciated cause of geriatric lung disease. Am J Respir Crit Care Med. 149:1994;1654-1658.
105. Prince D., Peterson D., Steiner R., et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 321:1989;863-868.
106. Laszlo A., Espolio Y., Auckenthaler A., Michel J.P., Janssens J.P. Azathioprine and low-dose corticosteroids for the treatment of cryptogenic organizing pneumonia in an older patient. J Am Geriatr Soc. 51:2003;433-434.
107. Lazor R., Vandevenne A., Pelletier A., Leclerc P., Court-Fortune I., Cordier J.F. Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. Am J Respir Crit Care Med. 162:(2 Pt1):2000;571-577.
108. Krafcik S.S., Covin R.B., Lynch J.P., Sitrin R.G. Wegener's granulomatosis in the elderly. Chest. 109:1996;430-437.
109. Philit F., Etienne-Mastroianni B., Parrot A., Guerin C., Robert D., Cordier J.F. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med. 166:2002;1235-1239.
110. Hedlund J., Hansson L. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection. 28:2000;68-73.
111. Smith R., Lipworth B., Cree I., Spiers E., Winter J. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest. 108:1995;1288-1291.
112. Hogarth M., Gallimore R., Savage P., et al. Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient. Age Ageing. 26:1997;153-158.
113. Niederman M.S., Mandell L.A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 163:2001;1730-1754.
114. Bernstein J.M. Treatment of community-acquired pneumonia - IDSA guidelines. Chest. 115:(suppl 3):1999;9-13.
115. Marcos M.A., Jimenez de Anta M.T., de la Bellacasa J.P., et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J. 21:2003;209-214.
116. Gutierrez F., Masia M., Rodriguez J.C., et al. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis. 36:2003;286-292.
117. Smith M.D., Derrington P., Evans R., et al. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol. 41:2003;2810-2813.
118. Pereira Gomes J.C., Pedreira WL Jr, Araujo E.M., et al. Impact of BAL in the management of pneumonia with treatment failure: positivity of BAL culture under antibiotic therapy. Chest. 118:2000;1739-1746.
119. Bartlett J.G., Breiman R.F., Mandell L.A., File TM Jr. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis. 26:1998;811-838.
120. Gleason P., Meehan T., Fine J., Galusha D., Fine M. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med. 159:1999;2562-2572.
121. Pavia M., Foresta M., Carbone V., Angelillo I. Influenza and pneumococcal immunization in the elderly: knowledge, attitudes, and practices among general practitioners in Italy. Public Health. 117:2003;202-207.
122. Lackner T.E., G Hamilton R., J Hill J., Davey C., Guay D.R. Pneumococcal polysaccharide revaccination: immunoglobulin G seroconversion, persistence, and safety in frail, chronically ill older subjects. J Am Geriatr Soc. 51:2003;240-245.
123. Rubins J.B., Alter M., Loch J., Janoff E.N. Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination. Infect Immun. 67:1999;5979-5984.
124. Gardner P. A need to update and revise the pneumococcal vaccine recommendations for adults. Ann Intern Med. 138:2003;999-1000.
125. Jackson L.A., Neuzil K.M., Yu O., et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 348:2003;1747-1755.
126. Ortqvist A. Pneumococcal vaccination: current and future issues. Eur Respir J. 18:2001;184-195.
127. Whitney C.G., Farley M.M., Hadler J., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 348:2003;1737-1746.
128. Ortqvist A., Hedlund J., Burman L.A., et al. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet. 351:1998;399-403.
129. Wagner C., Popp W., Posch M., Vlasich C., Rosenberger-Spitzy A. Impact of pneumococcal vaccination on morbidity and mortality of geriatric patients: a case-controlled study. Gerontology. 49:2003;246-250.
130. Honkanen P.O., Keistinen T., Miettinen L., et al. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine. 17:1999;2493-2500.
131. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 331:1994;778-784.
132. Anon. Prevention and control of influenza: recommendations of the advisory committee on Immunization practices. MMWR Morbid Mortal Wkly Rep. 51:2002;1-31.
133. Voordouw B.C., van der Linden P.D., Simonian S., van der Lei J., Sturkenboom M.C., Stricker B.H. Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Arch Intern Med. 163:2003;1089-1094.
134. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 348:2003;1322-1332.
135. Nordin J., Mullooly J., Poblete S., et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from three health plans. J Infect Dis. 184:2001;665-670.
136. Pregliasco F., Mensi C., Serpilli W., Speccher L., Masella P., Belloni A. Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly. Aging. 13:2001;38-43.
137. Deguchi Y., Nishimura K. Efficacy of influenza vaccine in elderly persons in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic. J Gerontol A Biol Sci Med Sci. 56:2001;M391-394.
138. Allsup S.J., Gosney M., Regan M., Haycox A., Fear S., Johnstone F.C. Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial. Gerontology. 47:2001;311-314.
139. Carman W.F., Elder A.G., Wallace L.A., et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 355:2000;93-97.
140. Christenson B., Lundbergh P., Hedlund J., Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet. 357:2001;1008-1011.
141. van der Steen J.T., Ooms M.E., van der Wal G., Ribbe M.W. Pneumonia: the demented patient's best friend? Discomfort after starting or withholding antibiotic treatment. J Am Geriatr Soc. 50:2002;1681-1688.
142. van der Steen J.T., Ooms M.E., Ader H.J., Ribbe M.W., van der Wal G. Withholding antibiotic treatment in pneumonia patients with dementia: a quantitative observational study. Arch Intern Med. 162:2002;1753-1760.
143. Brown N.K., Thompson D.J. Nontreatment of fever in extended-care facilities. N Engl J Med. 300:1979;1246-1250.
144. Fabiszewski K.J., Volicer B., Volicer L. Effect of antibiotic treatment on outcome of fevers in institutionalized Alzheimer patients. JAMA. 263:1990;3168-3172.
145. Morrison R.S., Siu A.L. Survival in end-stage dementia following acute illness. JAMA. 284:2000;47-52.
146. van der Steen J.T., Ooms M.E., Mehr D.R., van der Wal G., Ribbe M.W. Severe dementia and adverse outcomes of nursing home-acquired pneumonia: evidence for mediation by functional and pathophysiological decline. J Am Geriatr Soc. 50:2002;439-448.
147. Chelluri L., Grenvik A., Silverman M. Intensive care for critically ill elderly: mortality, costs, and quality of life. Review of the literature. Arch Intern Med. 155:1995;1013-1022.
148. Hamel M.B., Davis R.B., Teno J.M., et al. Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. Ann Intern Med. 131:1999;721-728.
149. Beauchamp T., Childress J. Principles of biomedical ethics. 3rd edn:1989;Oxford University Press, New York and Oxford.
150. Marcus E.L., Clarfield A.M., Moses A.E. Ethical issues relating to the use of antimicrobial therapy in older adults. Clin Infect Dis. 33:2001;1697-1705.
151. Prendergast T.J. Advance care planning: pitfalls, progress, promise. Crit Care Med. 29:(2 suppl):2001;N34-39.
152. Emanuel L.L., Emanuel E.J. The medical directive. A new comprehensive advance care document. JAMA. 261:1989;3288-3293.
153. Bosshard G., Wettstein A., Bar W. How stable is the attitude of aged people towards life-extending measures? Results of a 3-year follow-up in nursing home residents. Z Gerontol Geriatr. 36:2003;124-129.
154. Emanuel L.L., Emanuel E.J., Stoeckle J.D., Hummel L.R., Barry M.J. Advance directives. Stability of patients' treatment choices. Arch Intern Med. 154:1994;209-217.
155. Sullivan M., Ormel J., Kempen G.I., Tymstra T. Beliefs concerning death, dying, and hastening death among older, functionally impaired Dutch adults: a one-year longitudinal study. J Am Geriatr Soc. 46:1998;1251-1257.
156. Azoulay E. Opinions about surrogate designation: a population survey in France. Crit Care Med. 31:2003;1711-1714.
157. Bregenzer T., Conen D., Sakmann P., Widmer A. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med. 158:1998;151-156.
158. Soifer N., Borzak S., Edlin B., Weinstein R. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med. 158:1998;473-477.
159. Gomez-Merino E., Sancho J., Marin J., et al. Mechanical insufflation-exsufflation: pressure, volume, and flow relationships and the adequacy of the manufacturer's guidelines. Am J Phys Med Rehabil. 81:2002;579-583.
160. Bach J.R. Mechanical insufflation-exsufflation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest. 104:1993;1553-1562.